This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
Archives of Pathology & Laboratory Medicine
In 1993, Black and Welch published a prophetic article that foretold the diagnostic imaging-induced conundrum now known as overdiagnosis. Overdiagnosis is defined as detection of a medical condition that, if left undiagnosed, would cause no harm. Compelled by the above-cited authors and my own experiences, I advocate discussions of cancer overdiagnosis with medical students, house officers and faculty. The potential harms of cancer overdiagnosis include not only unnecessary surgery and complications, but also the emotional and financial tribulations incurred by cancer diagnosis and indefinite follow-up.
READ MORE
Oncology Nuse Advisor
Drug toxicity is often judged based on high-grade (grades 3-4) adverse events; however, many patients experience quality of life issues from lower-grade adverse effects. A recent study published in Cancer Management and Research suggests that assessment of cumulative drug toxicities, including adverse events of grades 1 and 2, may aid in predicting a patient's quality of life.
READ MORE
Newsweek
Most people who carry genes that raise their risk of developing certain forms of cancer are unaware of it, according to research.
Scientists at Yale mapped the genes of 50,726 adults and found more than 80 percent had a heightened risk of breast, ovarian, pancreatic and prostate cancer because of their genes but were unaware of their risk.
READ MORE
|
Promoted by
|
|
|
|
 |
Medical Xpress
Sometimes negative results can point researchers in the right direction.
In results published in PLOS ONE on Sept. 4, 2018, scientists at the Medical University of South Carolina examined a protein called vaccinia-related kinase 1 that they hypothesized was important for metastasis. They found that, rather than causing cancer cells to migrate and invade, VRK1 over-expression had the opposite effect.
READ MORE
Oncology Nurse Advisor
Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or anthracyclines for the treatment of breast cancer, according to a study published in the Aug. 1 issue of JACC: Cardiovascular Imaging. Mariana L. Henry, from the University of Texas MD Anderson Cancer Center in Houston, and colleagues used data from the Truven Health MarketScan (IBM Watson Health, Cambridge, Mass.) database to assess the rate of chemotherapy-related cardiotoxicity and to estimate adherence to recommendations for cardiac monitoring among 16,456 breast cancer patients (median age, 56 years) treated with chemotherapy (2009 to 2014).
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
News-Medical
Harnessing the immune system to treat cancer shows great promise in some patients, but for many, the response does not last long term. In an effort to find out why, Fred Hutchinson Cancer Research Center scientists are using a new technology to look at how cancer cells change under the pressure of immunotherapy treatments.
READ MORE
Clinical Oncology News
Health systems and oncology practices need to heed a wide range of reimbursement problems that can trigger negative payments for high-cost oncology medications, including outdated billing codes, poorly coordinated prior authorizations and using generic billing codes for monoclonals when specific codes have been published, according to a new analysis of payment records at a major academic center. For other centers with similar issues, there “are large financial opportunities associated with correcting reasons for suboptimal reimbursement,” reported a team of pharmacists at the 2018 annual conference of the Hematology/Oncology Pharmacy Association.
READ MORE
|
Promoted by
|
|
|
|
 |
CNN
Obesity is set to overtake smoking as the leading preventable cause of cancer in women in the U.K., a new report warns.
Cancer Research UK estimated that 23,000 British women will suffer from obesity-related cancers by 2035 — just 2,000 fewer than the number of cases caused by smoking.
By 2043 obesity will become the most common cause of cancer in women if current trends continue, the charity found.
READ MORE
St. Jude Children's Research Hospital via ScienceDaily
Scientists have identified another way the process that causes oil to form droplets in water may contribute to solid tumors, such as those associated with prostate and breast cancer. Researchers found evidence that mutations in the tumor suppressor gene SPOP contribute to cancer by disrupting a process called liquid-liquid phase separation.
READ MORE
 |
|
Doctors Without Borders/Médecins Sans Frontières (MSF) is actively recruiting general and trauma surgeons with experience in emergency obstetrics for international missions in developing countries. Learn more
|
|
Medical Xpress
A new study by scientists at the University of Liverpool highlights how a clinically approved lung cancer drug could potentially be "repurposed" to design new treatments for future cancer therapies.
The research, published in Science Signaling, focuses on a protein called TRIB2, which is linked to promoting survival and drug resistance in solid tumours and blood cancers and is therefore of particular interest as a therapeutic target.
READ MORE
| ACS CANCER PROGRAMS UPDATES |
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
 |
|
Dynamic online courses from the Association of Community Cancer Centers (ACCC) offer the tools your staff needs to help patients pay for treatment—while maximizing reimbursement at your cancer program. The Financial Advocacy Boot Camp explains all aspects of financial advocacy and is a great resource for new advocates and experienced professionals. Your team will be more prepared with this online curriculum. Learn More
|
|
ACS
2019 Call for Data
Due to the many changes and implementation delays in 2018, the NCDB 2019 Call for Data schedule will be adjusted to allow software vendors time to install v18 for their customers and registries an opportunity to catch up with abstracting the new data items and resubmit RQRS cases. At this time, the 2019 Call for Data is scheduled for April 1 – June 30, 2019, and both NAACCR v16 and v18 layouts will be accepted for submission.
As the NCDB prepares to roll out the Rapid Cancer Reporting System (RCRS) with our new technology partner IQVIA next year, we continue to build out the needed technological infrastructure to support this new system. RCRS will replace RQRS and other NCDB tools while introducing a single source of data submission for all of our hospital registries. RQRS has been down recently as some of these new development efforts have been integrated and tested.
Additionally, the NCDB is in the process of clarifying how CoC Standards 5.2, 5.5 and 5.6 will be rated for survey year 2019, taking into account the significant challenges that have been experienced across all hospitals due to this year of change. Further information will be provided on a separate communication.
STORE Manual
In response to the valuable feedback from cancer registrars, the copy of the Standards for Oncology Registry Entry (STORE) has been updated to allow users to save the document into the computer/local drive, copy and paste from the document, highlight and add comments. There were no changes in the text other than allowing these features. For clarifications on the STORE data items, please continue to utilize the CAnswer Forum. For program-specific questions, please contact ncdb@facs.org.
READ MORE
 |
|
Need to automate cancer coding at Budget Preserving costs? Let AI do the bulk coding and preserve valuable staff time for the most cryptic. HORIZON suite automates NAACR 2018 for 100% of your reportability assessments and 90%+ of your coding at better than manual accuracy, while undercutting manual costs. With ever-tightening budgets and workloads rising continuously and more data for analysis being demanded, www.hla-global.com
is your best option for the future.
|
|
AJCC
The AJCC Cancer Staging Manual, Eighth Edition is the first edition to have an electronic book (eBook) version. It is available for purchase now on Amazon and is the most current version of the manual (September 2018).
Since 1977, the American Joint Committee on Cancer (AJCC) has published eight editions of cancer staging manuals using contemporary, evidenced-based literature to build a common language of cancer for the care of cancer patients by clinicians and for the cancer surveillance community. The print version of the eighth edition was first published in October 2016 and went into effect for all cancer cases diagnosed on or after Jan. 1, 2018. The eighth edition presents evidence-based revisions for the staging of cancer for a number of organ sites. The chapters include the rationale and rules for staging; the definitions of tumor, lymph node involvement, and metastasis; stage groupings; and histologic grade.
There have been updates since the first printing of the eighth edition, all of which are incorporated in this eBook version available through Amazon’s Kindle. The Kindle version can be used on any device (PC, MAC, iPhone, iPad, Android) with the free Kindle app. The electronic version allows for highlighting, adding notes and bookmarks, and creating flashcards. The AJCC has a curated FAQ document to address common questions that can be accessed at cancerstaging.org. All other questions related to the eighth edition can be sent to ajcc@facs.org.
READ MORE
Clinical Research Program
As mentioned in prior communications, the 2018 DCIS Special Study opened July 16. We invite you to visit the 2018 Special Study on DCIS SharePoint site, which will house all materials you will need to participate in the study. We have created a universal login for this site; please note it is case sensitive:
Login: DCISStudy
Password: study2018.
All registrars and co-registrars will be able to access and download materials via the SharePoint site.
READ MORE
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2.
Special 25 percent discount! Expires Dec. 31.
Click here for the Springer order form.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
